Propranolol versus corticosteroids in the treatment of infantile hemangioma: A systematic review and meta-analysis

Plastic and Reconstructive Surgery

Volumn 131, Issue 3, 2013, Pages 601-613

  Izadpanah, Ali ^a,b,c   Izadpanah, Arash ^a,b,c   Kanevsky, Jonathan ^a,b,c   Belzile, Eric ^a,b,c   Schwarz, Karl ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c ST MARY S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PROPRANOLOL;

COMPARATIVE STUDY; HEMANGIOMA; HUMAN; INFANT; META ANALYSIS; REVIEW;

ADRENAL CORTEX HORMONES; HEMANGIOMA; HUMANS; INFANT; PROPRANOLOL;

MLCS; MLOWN;

EID: 84875051307     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31827c6fab     Document Type: Review

References (62)

1. Burns AJ, Navarro JA, Cooner RD. Classification of vascular anomalies and the comprehensive treatment of hemangiomas. Plast Reconstr Surg. 2009;124 (1 Suppl):69e-81e.
2. Léauté-Labrezè C, Tai?eb A. Efficacy of beta-blockers in infantile capillary haemangiomas: The physiopathological significance and therapeutic consequences (in French). Ann Dermatol Venereol. 2008;135:860-862.
3. Pandey A, Gangopadhyay AN, Gopol SC, et al. Twenty years' experience of steroids in infantile hemangioma: A developing country's perspective. J Pediatr Surg. 2009;44:688-694.
4. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104:1616-1623.
5. Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr. 1996;128:141-146.
6. Argenta LC, Bishop E, Cho KJ, Andrews AF, Coran AG. Complete resolution of life-threatening hemangioma by embolization and corticosteroids. Plast Reconstr Surg. 1982;70: 739-744.
7. Kushner BJ. The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast Reconstr Surg. 1985;76:517-526.
8. Prasetyono TO, Djoenaedi I. Efficacy of intralesional steroid injection in head and neck hemangioma: A systematic review. Ann Plast Surg. 2011;66:98-106.
9. Chantharatanapiboon W. Intralesional corticosteroid therapy in hemangiomas: Clinical outcome in 160 cases. J Med Assoc Thai. 2008;91(Suppl 3):S90-S96.
10. Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangiomas. J Coll Physicians Surg Pak. 2006;16:662-665.
11. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: Review of the literature. Int J Pediatr Otorhinolaryngol. 2010;74:338-342.
12. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope 2009;119:2051-2054.
13. Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: A review of the literature. Semin Ophthalmol. 2009;24:178-184.
14. Bigorre M, Van Kien AK, Valette H. Beta-blocking agent for treatment of infantile hemangioma. Plast Reconstr Surg. 2009; 123:195e-196e.
15. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73:1168-1172.
16. Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res. 2009;60:438-445.
17. Liggett SB, Cresci S, Kelly RJ, et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med. 2008;14:510-517.
18. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: Promise, peril, pathogenesis. Pediatr Dermatol. 2009;26: 642-644.
19. Leboulanger N, Fayoux P, Teissier N, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol. 2010;74:1254-1257.
20. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol. 2010; 146:775-778.
21. Pavlakovic H, Kietz S, Lauerer P, Zutt M, Lakomek M. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 2010;126:e1589-e1593.
22. Pérez RS, Mora PC, Rodríguez JD, Sánchez FR, de Torres Jde L. Treatment of infantile hemangioma with propranolol (in Spanish). Ann Pediatr (Barc.) 2010;72:152-154.
23. Blei F, Chianese J. Corticosteroid toxicity in infants treated for endangering hemangiomas: Experience and guidelines for monitoring. Int Pediatr. 1999;14:146-153.
24. Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: A review of 155 cases. J Pediatr Surg. 2000;35:420-423.
25. Chowdri NA, Darzi MA, Fazili Z, Iqbal S. Intralesional corticosteroid therapy for childhood cutaneous hemangiomas. Ann Plast Surg. 1994;33:46-51.
26. Iwanaka T, Tsuchida Y, Hashizume K, Kawarasaki H, Utsuki T, Komuro H. Intralesional corticosteroid injection with short-term oral prednisolone for infantile hemangiomas of the eyelid and orbit. J Pediatr Surg. 1994;29:482-486.
27. Kushner BJ. Local steroid therapy in adnexal hemangioma. Ann Ophthalmol. 1979;11:1005-1009.
28. Kelly ME, Juern AM, Grossman WJ, Schauer DW, Drolet BA. Immunosuppressive effects in infants treated with cortico-steroids for infantile hemangiomas. Arch Dermatol. 2010;146: 767-774.
29. Zhou Q, Yang XJ, Zheng JW, Wang YA, Zhang ZY. Short-term high-dose oral prednisone on alternate days is safe and effective for treatment of infantile hemangiomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:166-167.
30. Rössler J, Wehl G, Niemeyer CM. Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr. 2008;167:813-815.
31. Pope E, Krafchik BR, Macarthur C, et al. Oral versus highdose pulse corticosteroids for problematic infantile hemangiomas: A randomized, controlled trial. Pediatrics 2007;119: e1239-e1247.
32. Greene AK, Couto RA. Oral prednisolone for infantile hemangioma: Efficacy and safety using a standardized treatment protocol. Plast Reconstr Surg. 2011;128:743-752.
33. Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol. 2000;29:361-366.
34. Narcy P, Contencin P, Bobin S, Manac'h Y. Treatment of infantile subglottic hemangioma: A report of 49 cases. Int J Pediatr Otorhinolaryngol. 1985;9:157-164.
35. Price CJ, Lattouf C, Baum B, et al. Propranolol vs corticosteroids for infantile hemangiomas: A multicenter retrospective analysis. Arch Dermatol. 2011;147:1371-1376.
36. Schupp CJ, Kleber JB, Günther P, Holland-Cunz S. Propranolol therapy in 55 infants with infantile hemangioma: Dosage, duration, adverse effects, and outcome. Pediatr Dermatol. 2011;28:640-644.
37. Bagazgoitia L, Hernández-Martín A, Torrelo A. Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol. 2011;28:658-662.
38. Lv MM, Fan XD, Su LX. Propranolol for problematic head and neck hemangiomas: An analysis of 37 consecutive patients. Int J Pediatr Otorhinolaryngol. 2012;76:574-578.
39. Fuchsmann C, Quintal MC, Giguere C, et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg. 2011;137:471-478.
40. Zaher H, Rasheed H, Hegazy RA, Hegazy RA, Abdelhalim DM, Gawdat HI. Oral propranolol: An effective, safe treatment for infantile hemangiomas. Eur J Dermatol. 2011;21: 558-563.
41. de Graaf M, Breur JM, Raphael MF, Vos M, Breugem CC, Pasmans SG. Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants. J Am Acad Dermatol. 2011;65:320-327.
42. Schiestl C, Neuhaus K, Zoller S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr. 2011;170:493-501.
43. Missoi TG, Lueder GT, Gilbertson K, Bayliss SJ. Oral propranolol for treatment of periocular infantile hemangiomas. Arch Ophthalmol. 2011;129:899-903.
44. Al Dhaybi R, Superstein R, Milet A, et al. Treatment of periocular infantile hemangiomas with propranolol: Case series of 18 children. Ophthalmology 2011;118:1184-1188.
45. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011;128:e259-e266.
46. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg. 2010;125:420-421.
47. Zvulunov A, McCuaig C, Frieden IJ, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: A multicenter retrospective study. Pediatr Dermatol. 2011;28:94-98.
48. Chai Q, Chen WL, Huang ZQ, Zhang DM, Fan S, Wang L. Preliminary experiences in treating infantile hemangioma with propranolol. Ann Plast Surg. Epublished ahead of print May 27, 2011.
49. Bertrand J, McCuaig D, Dubois J, Hatami A, Ondrejchak S, Powell J. Propranolol versus prednisone in the treatment of infantile hemangiomas: A retrospective comparative study. Pediatr Dermatol. 2011;28:649-654.
50. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg. 2011;64: 292-299.
51. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatening infantile haemangioma: A dramatic response to propranolol. J Eur Acad Dermatol Venereol. 2009;23:1465-1466.
52. Itani MH, Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Rep. 2009;2009:bcr0120091476.
53. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope 2010;120:676-681.
54. Bonifazi E, Acquafredda A, Milano A, Montagna O, Laforgia N. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol. 2010;27:195-196.
55. Sans V, de la Rogue ED, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009; 124:e423-e431.
56. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol. 2009;26:610-614.
57. Mahadevan M, Cheng A, Barber C. Treatment of subglottic hemangiomas with propranolol: Initial experience in 10 infants. ANZ J Surg. 2011;81:456-461.
58. Mistry N, Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol. 2010;124:1329-1332.
59. Cushing SL, Boucek RJ, Manning SC, Sidbury R, Perkins JA. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol Head Neck Surg. 2011;144:78-84.
60. Jin YB, Lin XX, Ye XX, et al. A prospective study of propranolol as first-line treatment for problematic infantile hemangioma in China. Zhonghua Zheng Xing Wai Ke Za Zhi. 2011;27:170 -173.
61. Léauté-Labréze C, Sans-Martin V. Infantile hemangioma. Presse Med. 2010;39:499 -510.
62. Breur JM, de Graaf M, Breugem CC, et al. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: A case report. Pediatr Dermatol. 2011;28: 169-171.